PJP vs. GDOC
PJP (Invesco Dynamic Pharmaceuticals ETF) and GDOC (Goldman Sachs Future Health Care Equity ETF) are both Health & Biotech Equities funds. PJP is passively managed, while GDOC is actively managed. Over the past 3 years, PJP returned 13.31%/yr vs 0.05%/yr for GDOC. A 0.75 correlation means they provide meaningful diversification when combined. PJP charges 0.58%/yr vs 0.75%/yr for GDOC.
Performance
PJP vs. GDOC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PJP achieves a 2.90% return, which is significantly higher than GDOC's -7.76% return.
PJP
- 1D
- 1.20%
- 1M
- 1.29%
- YTD
- 2.90%
- 6M
- 2.29%
- 1Y
- 34.73%
- 3Y*
- 13.31%
- 5Y*
- 7.62%
- 10Y*
- 6.15%
GDOC
- 1D
- 0.41%
- 1M
- 1.93%
- YTD
- -7.76%
- 6M
- -9.87%
- 1Y
- 5.18%
- 3Y*
- 0.05%
- 5Y*
- —
- 10Y*
- —
PJP vs. GDOC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
PJP Invesco Dynamic Pharmaceuticals ETF | 2.90% | 27.98% | 9.63% | -2.18% | -2.16% | 0.52% |
GDOC Goldman Sachs Future Health Care Equity ETF | -7.76% | 10.74% | -1.66% | 4.60% | -17.12% | -2.77% |
Correlation
The correlation between PJP and GDOC is 0.74, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.74 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.71 |
Correlation (All Time) Calculated using the full available price history since Nov 12, 2021 | 0.75 |
The correlation between PJP and GDOC has been stable across timeframes, ranging from 0.71 to 0.75 - a consistent structural relationship.
PJP vs. GDOC - Sectors Allocation Comparison
Sectors
PJP
GDOC
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
PJP
GDOC
Basic Materials
PJP
-
GDOC
-
Communication Services
PJP
-
GDOC
-
Consumer Cyclical
PJP
-
GDOC
-
Consumer Defensive
PJP
-
GDOC
Energy
PJP
-
GDOC
-
Financial Services
PJP
-
GDOC
-
Industrials
PJP
-
GDOC
-
Real Estate
PJP
-
GDOC
-
Technology
PJP
-
GDOC
-
Utilities
PJP
-
GDOC
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PJP vs. GDOC — Risk / Return Rank
PJP
GDOC
PJP vs. GDOC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and Goldman Sachs Future Health Care Equity ETF (GDOC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PJP | GDOC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.80 | ||
| Sortino ratioReturn per unit of downside risk | +2.41 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.07 | +0.29 |
| Calmar ratioReturn relative to maximum drawdown | 3.70 | 0.33 | +3.36 |
| Martin ratioReturn relative to average drawdown | 11.55 | 0.76 | +10.78 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PJP | GDOC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.13 | 0.33 | +1.80 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.47 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.34 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.59 | -0.19 | +0.78 |
Drawdowns
PJP vs. GDOC - Drawdown Comparison
The maximum PJP drawdown since its inception was -37.06%, which is greater than GDOC's maximum drawdown of -31.01%. Use the drawdown chart below to compare losses from any high point for PJP and GDOC.
Loading charts...
Drawdown Indicators
| PJP | GDOC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -37.06% | -31.01% | -6.05% |
Max Drawdown (1Y)Largest decline over 1 year | -9.44% | -15.67% | +6.23% |
Max Drawdown (3Y)Largest decline over 3 years | -16.27% | -22.51% | +6.24% |
Max Drawdown (5Y)Largest decline over 5 years | -17.51% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -33.95% | — | — |
Current DrawdownCurrent decline from peak | -2.94% | -15.53% | +12.59% |
Average DrawdownAverage peak-to-trough decline | -8.85% | -15.90% | +7.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.02% | 6.83% | -3.81% |
Volatility
PJP vs. GDOC - Volatility Comparison
Invesco Dynamic Pharmaceuticals ETF (PJP) has a higher volatility of 5.33% compared to Goldman Sachs Future Health Care Equity ETF (GDOC) at 4.90%. This indicates that PJP's price experiences larger fluctuations and is considered to be riskier than GDOC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PJP | GDOC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.33% | 4.90% | +0.43% |
Volatility (6M)Calculated over the trailing 6-month period | 12.02% | 11.61% | +0.41% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.38% | 15.64% | +0.74% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.17% | 18.79% | -2.62% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.39% | 18.79% | -0.40% |
PJP vs. GDOC - Expense Ratio Comparison
PJP has a 0.58% expense ratio, which is lower than GDOC's 0.75% expense ratio.
Dividends
PJP vs. GDOC - Dividend Comparison
PJP's dividend yield for the trailing twelve months is around 0.99%, more than GDOC's 0.35% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GDOC Goldman Sachs Future Health Care Equity ETF | 0.35% | 0.32% | 0.02% | 0.55% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PJP Invesco Dynamic Pharmaceuticals ETF | 0.99% | 0.98% | 0.97% | 1.01% | 0.95% | 0.81% | 0.75% | 0.77% | 1.12% | 0.65% | 0.91% | 5.49% |
Frequently Asked Questions
PJP and GDOC have a correlation of 0.74, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PJP has higher volatility (5.33%) compared to GDOC (4.90%). In terms of maximum drawdown, PJP dropped -37.06% vs GDOC's -31.01%.
On 3-year performance, PJP leads with 13.31% vs 0.05% for GDOC. On fees, PJP is cheaper at 0.58% per year. On volatility, GDOC has been the lower-risk option at 4.90%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, PJP has performed better with a 13.31% return vs 0.05%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PJP is cheaper with a 0.58% expense ratio, compared with 0.75% for GDOC.
PJP has the higher dividend yield at 0.99%, compared with 0.35% for GDOC.
They also come from different issuers: Invesco and Goldman Sachs. Their fees differ too: 0.58% for PJP and 0.75% for GDOC.
PJP currently has the higher Sharpe Ratio (2.13 vs 0.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PJP and GDOC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer